PRIMACOR

This brand name is authorized in Brazil, Hong Kong, Malta, Mexico, New Zealand, Singapore, United Kingdom

Active ingredients

The drug PRIMACOR contains one active pharmaceutical ingredient (API):

1 Milrinone UNII 9K8XR81MO8 - MILRINONE LACTATE

Milrinone is a positive inotrope and vasodilator, with little chronotropic activity. It also improves left ventricular diastolic relaxation. It is a selective inhibitor of peak III phosphodiesterase isoenzyme in cardiac and vascular muscle. It produces slight enhancement of A-V node conduction, but no other significant electrophysiological effects. Read about Milrinone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PRIMACOR Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01CE02	Milrinone	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CE Phosphodiesterase inhibitors
Discover more medicines within C01CE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720070075717
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 46469
Country: HK	Department of Health Drug Office	Identifier(s): 36347
Country: MT	Medicines Authority	Identifier(s): AA565/54501
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 255M99
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5324
Country: SG	Health Sciences Authority	Identifier(s): 07633P